Bio-artificial ultrafiltration pancreas

• US 4,578,191 A
• Filed: 08/01/1983
• Issued: 03/25/1986
• Est. Priority Date: 08/09/1982
• Status: Expired due to Fees

• Current Assignee: Centre National De La Recherche Scientifique
• Original Assignee: Centre National De La Recherche Scientifique
• Inventors: Reach, Gerard, Jaffrin, Michel
• Primary Examiner(s): SPEAR JR, FRANK
• Application Number:
  US06/519,315
• Time in Patent Office: 967 Days
• Field of Search: 210/321.4, 210/321.1, 210/456, 210/632, 210/433.2, 210/638, 210/648, 210/363.2, 3/1, 435/284
• US Class Current: 210/323.2
• CPC Class Codes: A61F 2/022 Artificial gland structures using bioreactors hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36
• CPC Class Codes: A61M 1/3687 Chemical treatment A61M1/3675 takes precedence
• CPC Class Codes: A61M 1/3689 by biological cells
• CPC Class Codes: A61M 1/80 Suction pumps A61M1/64, A61M1/71, A61M60/00 take precedence

Abstract

The bio-artifical pancreas comprises islands of Langerhans contained in a volume defined by two approximately parallel ultrafiltration membranes, able to be formed by two successive portions of the same flat membrane or the same hollow fiber. The surfaces of the membrane opposite the volume occupied by the islands are successively swept by the same blood stream over a length greater by at least one order of size than the distance separating the membranes.

Claims

1. A bio-artificial pancreas comprising:

two ultrafiltration membranes having approximately parallel substantially planar confronting surfaces spaced apart a distance such that the space there between defines a volume of small thickness;

islets of Langerhans contained in said compartment;

means defining a blood path whereby blood flowing along said blood path successively sweeps said surfaces of said two membranes opposite said volume occupied by said islets of Langerhans over a length greater by at least one order of magnitude than the distance which separates said membranes;

said membranes being constructed and arranged such that said volume fulfills the condition;

space="preserve" listing-type="equation">V.sub.i ≦

(S)(P.sub.M)(τ

)(Δ

P/8)

in which

V_i =said volume,

S=total membrane area,

P_M =hydraulic permeability of membrane,

τ

=acceptable time constant, and

Δ

P=available drive pressure.

2. The bio-artificial pancreas according to claim 1, wherein said membranes are two successive portions of the same flat membrane folded in a U.

3. The bio-artificial pancreas according to claim 2 further comprising a lattice defining the thickness of said volume and reducing said volume, said lattice being located between said confronting surfaces.

4. The bio-artificial pancreas according to claim 3, wherein the islets of Langerhans are disposed in the openings of said lattice.

5. The bio-artificial pancreas according to claim 2, wherein said volume only contains islets of Langerhans in the part distant from the curved end of the U.

6. The bio-artificial pancreas according to claim 2, wherein the path of the blood stream presents a constriction for creating a pressure drop proximate the curved end of the U.

7. The bio-artificial pancreas according to claim 1, wherein said two ultrafiltration membranes comprise approximately parallel confronting walls of a U-shaped hollow ultrafiltrating fiber.

8. A bio-artificial pancreas according to claim 1 wherein said islets of Langerhans are located in a cloth bag accommodated in said volume.

9. A bio-artificial pancreas according to claim 1 further comprising a member for supporting said membranes and wherein said blood path comprises one or more grooves formed in said membrane supporting member.

10. A bio-artificial pancreas according to claim 1 wherein said ultrafiltration membranes comprise a hollow ultrafiltration fiber formed into two mutually parallel substantially planar sheets forming said confronting planar surfaces, said blood path defining means comprising said hollow ultrafiltration fiber.